Cross-cultural translation and adaptation of Functional Assessment of Cancer Therapy - Multiple Myeloma tool - MM1 and LEU3 - for Portuguese
Einstein (Säo Paulo)
;
20: eAO4457, 2022. graf
Article
Dans Anglais
| LILACS
| ID: biblio-1360407
ABSTRACT
ABSTRACT Objective To describe of the translation from English to Portuguese and adaption process of subitems of the Functional Assessment of Cancer Therapy - Multiple Myeloma. Methods In the first phase, translations from English into Portuguese of two subitems of Functional Assessment of Cancer Therapy - Multiple Myeloma were performed. Subsequently, a consensus and back translation were conducted, and, finally, translation and back translations were reviewed by four independent bilingual experts. In the second phase, the translated subitems were applied, along with a questionnaire, to 10 native Portuguese speakers patients with multiple myeloma. Results There was a recognition of the translation process in its first version applied to 10 patients with multiple myeloma, whose reported no difficult to understand the translated and validated instrument. Patients also did not find the content irrelevant or offensive, and they did not suggested changes. Conclusion The subitems of the Functional Assessment of Cancer Therapy - Multiple Myeloma were translated from English into Portuguese following the proposed methodology and there was not need of readjustments. This process allowed this instrument of quality of life, which is widely known to be beneficial in the management of patients with multiple myeloma, to be used among our population.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Comparaison interculturelle
/
Myélome multiple
Limites du sujet:
Humains
Pays comme sujet:
Amérique du Sud
/
Brésil
/
Europe
langue:
Anglais
Texte intégral:
Einstein (Säo Paulo)
Thème du journal:
Médicament
Année:
2022
Type:
Article
Pays d'affiliation:
Brésil
Institution/Pays d'affiliation:
Centro Universitário FMABC/BR
/
Hospital Israelita Albert Einstein/BR
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS